Characterization of a soluble form of CD58 in synovial fluid of patients with rheumatoid arthritis (RA)

Clinical and Experimental Immunology

Volumn 104, Issue 3, 1996, Pages 460-466

  Hoffmann, J C ^a,b   Bayer, B ^a   Zeidler, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CD2; CD58; LFA 3; Rheumatoid arthritis; Soluble adhesion molecules

Indexed keywords

CD2 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE;

EID: 0030010671     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.41749.x     Document Type: Article

References (35)

1. Panayi GS, Lanchbury JS, Kingsley G. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35:729-5.
2. Panayi GS. The immunopathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 1992; 10:305-7.
3. Cronstein BN, Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum 1993; 36:147-57.
4. Pitzalis C. Adhesion and migration of inflammatory cells. Clin Exp Rheumatol 1993 11 (Suppl. 8):S71-76.
5. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S. Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol 1993; 11:331-9.
6. Patarroyo M, Prieto J, Rincon J et al. Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol Rev 1990; 114:67-108.
7. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367:425-8.
8. Emilie D, Wallon C, Galanaud P, Fischer A, Olive D, Delfraissy JF. Role of the LFA3 CD2 interaction in human specific B cell differentiation. J Immunol 1988; 141:1912-8.
9. + T lymphocytes. J Immunol 1992; 148:1985-92.
10. Meuer SC, Hussey RE, Fabbi M et al. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 1984; 36:897-906.
11. Rothlein R, Kishimoto TK, Mainolfi E. Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J Immunol 1994; 152:2488-95.
12. Webb DS, Shimizu Y, van Seventer GA, Shaw S, Gerrard TL. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 1990; 249:1295-7.
13. Gruber MF, Webb DS, Gerrard TL. Stimulation of human monocytes via CD45, CD44, and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-1 beta. J Immunol 1992; 148:1113-8.
14. Brod SA, Purvee M, Benjamin D, Hafler DA. Cross-linking of CD59 and of other glycosyl phosphatidylinositol-anchored molecules on neutrophils triggers cell activation via tyrosine kinase. Eur J Immunol 1993; 23:2841-50.
15. Hughes CC, Savage CO, Pober JS. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990; 171:1453-67.
16. Takahashi H, Soderstrom K, Nilsson F, Kiessling R, Patarroyo M. Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patients. Eur J Immunol 1992; 22:2879-85.
17. + cell subsets in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1994; 21:1003-10.
18. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL target interactions. J Immunol 1993; 131:611-6.
19. Albert-Wolf M, Meuer SC, Wallich R. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway. Int Immunol 1991; 3:1335-47.
20. Dengler, TJ, Hoffmann JC, Knolle P, Albert-Wolf M, Roux M, Wallich R, Meuer SC. Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3). Eur J Immunol 1992; 22:2809-17.
21. Arulanandam AR, Withka JM, Wyss DF et al. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC′C″ face of the human CD2 adhesion domain. Proc Natl Acad Sci USA 1993; 90:11613-7.
22. Arulanandam AR, Kister A, McGregor MJ, Wyss DF, Wagner G, Reinherz EL. Interaction between human CD2 and CD58 involves the major 3 sheet surface of each of their respective adhesion domains. J Exp Med 1994; 180:1861-71.
23. Recny MA, Luther MA, Knoppers MH et al. N-glycosylalion is required for human CD2 immunoadhesion functions. J Biol Chem 1992; 267:22428-34.
24. Hoffmann JC, Dengler TJ, Knolle PA, Albert-Wolf M, Roux M, Wallich R, Meuer SC. A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids. Eur J Immunol 1993; 23:3003-10.
25. Hoffmann JC, Räuker H-J, Krüger H, Bayer B, Zeidler H. Decreased levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in sera and synovial fluids of patients with rheumatoid arthritis. Clin Exp Rheumatol 1996; 14:23-29.
26. Pruzanski W, Russell ML, Gordon DA, Ogryzlo MA. Serum and synovial fluid proteins in rheumatoid and degenerative joint disease. Am J Med Sci 1973; 265:483-9.
27. Kushner I, Somerville JA. Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum 1971; 14:560-8.
28. Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981; 24:1550-9.
29. Rowe IF, Sheldon J, Riches PG, Keat ACS. Comparative studies of serum and synovial C reactive protein concentrations. Ann Rheum Dis 1987; 46:721-6.
30. Wallis WJ, Simkin PA, Nelp WB. Protein traffic in human synovial effusions. Arthritis Rheum 1987; 30:57-63.
31. Shine B, Bourne JT, Baig FB, Dacre J, Doyle DV. C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease. Ann Rheum Dis 1991; 50:32-35.
32. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
33. Pepinsky RB, Chen LL, Meier W, Wallner BP. The increased potency of cross-linked lymphocyte function-associated antigen-3 (LFA-3) multimers is a direct consequence of changes in valency. J Biol Chem 1991; 266:18244-9.
34. Hoffmann JC, Autschbach F, Rensch K, Dengler TJ, Wallich R, Meuer SC. Cytokine stimulation augments the release of soluble CD58 (LFA-3) from various human cell lines. Immunobiology 1992; 186:133 (Abstr.).
35. Hoffmann JC, Herklotz C, Zeidler H, Bayer B, Accialini T, Westermann J. Suppresion of rat adjuvant arthritis by treatment with anti-CD2 monoclonal antibodies. Arthritis Rheum 1995; 38 (Suppl.):S156 (Abstr.).